UMEM Educational Pearls

Bradycardias caused by poisoning are due to the toxin's effects on cardiovascular receptors and cellular channels and transport mechanisms and are often refractory to standard ACLS drugs. The most common drug classes responsible for bradycardias are calcium channel and beta blockers and digoxin (cardiac glycosides). Sodium channel blockers, clonidine, and opiates also can cause bradycardias. Antidotes are as follows:

• Glucagon 5-10mg IV bolus followed by 1-5 mg/hr (Always pretreat with antiemetic) - Beta Blockers
• Calcium infusion 1-3 grams IV Bolus - Calcium Channel Blockers
• High Dose Insulin Euglycemic therapy of reg insulin 0.5-2 unit/kg Bolus (ie. 100 Units) with D50 IV bolus followed by reg insulin 0.5-1 units/kg/hr and dextrose 0.5 grams/kg/hr - Calcium channel and Beta Blockers
• **Intravenous Lipid Emulsion therapy bolus 1.5 mL/kg of ILE 20% followed by an infusion of 0.25 mL/kg/min-  Very small subset of toxins. See below.
• Atropine 2mg IV - Acetylcholinestrase inhibitors (Organophosphates)
• Sodium Bicarbonate 1-3 amps IV - Sodium Channel Blockers
• Digibind  for acute toxicity10 vials IV (20 Vials in cardiac arrest) and for chronic toxicity 2 vials and repeat as needed - Cardiac gylcosides
• Narcan 2 mg IV repeat boluses up to 10 mg- Opiates and Clonidine

** ILE is recommended only in life threatening poisonings where other accepted therapies have been use first or in cardiac arrest clinical scenarios. 

Show References

Linezolid, an antimicrobial agent in the oxazolidinone class, often used to cover MRSA and/or VRE, is a reversible MAOI that increases the risk of serotonin syndrome, particularly when administered with other serotonergic agents.

In 2011, the US FDA issued a warning against concomitant use of Linezolid and other serotonergic agents, particularly SSRIs and SNRIs.  When use of linezolid is absolutely indicated, an appropriate washout period prior to initiation was recommended.

Based on published reports and retrospective reviews, the incidence of linezolid-associated serotonin toxicity is between 0.54% and 18.2%.

A study published in the Journal of Clinical Psychopharmacology in Oct 2017 examined the incidence of serotonin syndrome with combined use of linezolid and SSRIs/SNRIs compared with linezolid alone and though there was a trend toward increased incidence in patients on SSRI/SNRIs, the authors were unable to find a statistically significant difference.

Several flaws:

-Study was retrospective

-Incidence of serotonin syndrome in both groups was very low: 1/87 (1.1%) in Linezolid + SSRI/SNRI group compared to 1/261 (0.4%) in Linezolid alone group.

-Patients in “Linezolid alone” group  were not on SSRIs or SNRIs, but were allowed to be on other serotonergic medications.

Despite this study, there are many (>30) case reports of Linezolid-associated serotonin syndrome in patients taking other serotonergic agents.

Cyproheptadine (the “antidote”) is an H1 antagonist and nonspecific serotonin antagonist.  A single case study published in 2016, reported successful use of cyproheptadine for prophylaxis against serotonin toxicity in a patient with schizophrenia, depression, and severe osteomyelitis requiring treatment with linezolid while on fluoxetine.

Bottom Line:

Risk of linezolid-associated serotonin syndrome may be lower than previously thought, however, it is still not recommended for use in patients taking concomitant serotonergic agents without an appropriate washout period.  

In case of resistant infection with no other antibiotic treatment options, the risks and benefits of concomitant administration must be weighed seriously and providers must familiarize themselves with and be vigilant in watching for signs/symptoms of serotonin toxicity.

In situations where use of linezolid is unavoidable in patients on concomitant serotonergic agents, prophylactic cyproheptadine may be considered.

Show References

Female Athlete Triad

1. Low energy availability
   1. With or without eating disorders
2. Menstrual dysfunction
3. Low bone mineral density (BMD)

Energy availability considers the amount of remaining energy for metabolic processes based on calories takin in with eating and calories burned through exercise or both.

Menstrual dysfunction occurs as a result of low energy availability causing decreased GnRH inhibition and ovarian suppression and decreased estrogen.

Low bone mineral density occurs due to amenorrhea and decreased energy availability. Estrogen limits bone resorption (stimulates calcitonin and renal calcium retention).

This is very important for young girls as by age 12 they have 83% of their total BMD & 95% two years after menarche.

If you see an athlete in the ED with one component of the triad, inquire about the other two. A 15yo athlete with a stress fracture may not realize that her disordered eating, excessive exercise or amenorrhea may by contributing factors and may benefit from follow up with PCP, dietitian, Gyn, etc.

Clonidine, (central alpha-2 receptor agonist) can produce opioid-like toxidrome in addition to its cardiac effects (bradycardia and hypotension). Previous studies have shown that naloxone has variable (~40%) success in reversing CNS/respiratory depression and cardiac effect.

A recent retrospective study (n=51) of pediatric poisoning showed that administration of 5 to 10 mg had improved reversal of clonidine toxicity.

Total of 51 somnolent patients: 5- 10 mg of naloxone reversed 40 patients

• 22 patients awoke with 6 mg or less
• Bradycardia reversed in 17 of 44 patients
• Hypotension reversed in 7 of 11 patients

There was no adverse effect from naloxone administration.

Repeat administration of naloxone was required in some patients.

Bottom line

• For pediatric clonidine toxicity, consider initial naloxone dose of 5 mg IV. 

Show References

Show Additional Information

Show References

In the past couple of weeks, there have been reports from Illinois about patients using adulterated synthetic cannabinoids, resulting in elevated INR and bleeding. To date, there are approximately 70 cases including 3 fatalities. Brodifacoum, a long-acting vitamin K mediated anticoagulant (similar to warfarin) has been identified in 10 cases. Brodifacoum is frequently used as rodenticide.

This week, Maryland Poison Center received our first notification of a patient with bleeding and elevated INR due to suspected adulterated synthetic cannabinoid use.

When evaluating our patient population:

• Ask about synthetic cannabinoid use in patients with unexplained bleeding and elevated INR
• Carefully examine patients with synthetic cannabinoid intoxication for any signs of bleeding, bruising or petechiae.  
   

Patient management of suspected cases:

• ACTIVELY bleeding:
  • Fresh frozen plasma
  • Activated prothrombin complex concentrate (KCentra®) in life threatening bleeding.
  • Vitamin K 10 mg IV
  • *** Start oral vitamin K at 50 mg TID and titrate to goal INR < 2 ***
• NOT bleeding and INR < 10: vitamin K 50 mg PO BID with titration if needed.
• NOT bleeding and INR > 10: vitamin K 50 mg PO TID with titration if needed.

Patient can be discharged when INR < 2 is achieved with oral vitamine K regimen only (without recent FFP infusion).

Review of published cases highlights that most patients are started on a median doses of 100 mg/day (range: 15 - 600 mg) and stabilize on a PO regimen of 50-100 mg/day. Prolonged PO vitamin K course of 2 – 3 months or longer should be anticipated.

Pease call the Maryland Poison Center at 1-800-222-1222 as we are working with the Maryland Department of Health and CDC to track these cases. 

Show Additional Information

Show References

Acute on Chronic Liver Failure

• Patients with cirrhosis can comprise up to 5% of an ICU population.
• Many of these patients will present to the ED, and be admitted to the ICU, for acute on chronic liver failure.
• A few management pearls for these patients include:
  • Consider albumin in patients with hepatorenal syndrome, large-volume paracentesis (> 5 L), and SBP
  • Norepinephrine is the initial vasopressor of choice; target a MAP ≥ 60 mm Hg
  • The INR does not accurately reflect bleeding in these patients.  Use platelet count and fibrinogen.
  • There is no need to correct coagulation abnormalities prior to routine procedures (e.g., central venous catheterization)

Show References

25% of U.S. health care spending goes to the 6% of people who die every year. ICUs account for 20% of all health care costs. A new study has shown that patients with POLST (Physician Orders for Life-Sustaining Treatments) forms are less likely to receive unwanted life sustaining treatments when compared to patients with traditional Do-Not-Resuscitate orders (http://www.ohsu.edu/polst/). Using the POLST did not impact the degree of comfort care received for symptom management and helped individuals make more informed choices about the type and level of end-of-life care they wish to receive.

Show References

• The current Surviving Sepsis Campaign Guidelines recommend treating septic patients with bundled care to improve outcomes. 
• The first bundle should be completed within 3 hours of suspicion of sepsis and includes:
  • Obtain blood cultures before antibiotics
  • Obtain lactate level
  • Administer broad-spectrum antibiotics
  • Administer 30mL/kg crystalloid fluid for hypotension  (MAP <65, lactate >4)

• A recent study in Critical Care Medicine examined the time frame when the delay of specific 3-hour bundle guideline recommendations applied to severe sepsis or septic shock becomes harmful and impacts mortality.
• Retrospective cohort study of all adult patients hospitalized with severe sepsis or septic shock from January 2011 to July 31, 2015. Of the 5,072 patients enrolled, 95.8% received the 3-hour bundle.
• Results:
  • Overall in-hospital mortality = 27.8%
  • If patient did not receive any of the 3-hr bundle items, in-house mortality = 41.1%
  • Statistically significant delays were linked to increased mortality for all bundle items
  • Delays beyond 3 hours were associated with minimal additional harm already caused by the 3-hour delay

Bottom Line: Implement sepsis protocols as soon as sepsis is suspected prior to the end of the 3 hour treatment window.

Show References

• Stevens-Johnsons like rash and mucositis
• Most common in children and adolescents, with a mean age of 12 years old
• More common in males than females, 2:1
• Prodromal symptoms of cough, fever, and malaise precede
• Mucositis far out of proportion to body rash, 90% vs 10%
• Mucositis is primarily oral > ocular > genital in distribution, and can be severe
• Body rash may involve palms and soles
• Complications: dehydration, GIB, epiglottitis, blindness, pericardial effusion
• Testing: PCR nasal wash/BAL; agglutination assays IgM/IgG
• Treatment: azithromycin and supportive care; occasionally steroids; rarely IVIG
• Unlike Stevens-Johnsons, prognosis is good.

Patients may present atypically with ischemic strokes, reporting symptoms such as face or hemibody pain, lightheadedness, mental status change, headache and non-neurological symptoms.

Up to 25% of patients will have these symptoms.

Women are more likely than men to present with these atypical (or “nontraditional”) symptoms, especially altered mental status.

Show References

Background:

Animal studies in post-ROSC management after cardiac arrest have repeatedly demonstrated poorer neurological outcomes with higher amounts of oxygen administration.¹ Studies in humans have also demonstrated dose-dependent associations between hyperoxia and poorer neurologic outcomes, as well as in-hospital mortality.^2,3

Recent Data

A retrospective analysis of prospectively-collected data in 187 OHCA patients undergoing postarrest care with targeted temperature management found worse neurologic outcomes in patients experiencing hyperoxia in the first 6 hours following ROSC.⁴

This association was dose-dependent, with worsening outcomes as with higher PaO2 levels >200.

• Adjusted OR 1.659 [95% CI, 1.194–2.305] at 200 mmHg
• Adjusted OR 3.969 [95% CI, 1.450–10.862] for 300 mmHg
• Trend towards worsening at 150 mmHg that did not reach statistical significance

Bottom Line:

• Our initial management of these patients in the ED is crucial
• In post-cardiac arrest patients, titrate immediate FiO2 to SpO2 ≥ 94% and PaO2 75 to 150/200 mmHg to avoid hyperoxia and worsening neurologic and survival outcomes. 

Show References

Boutonniere Deformity
aka buttonhole deformity

Misdiagnosed as a “jammed” or “sprained” finger

• Deformity occurs at the PIP joint
• Trauma to the PIP joint can cause the joint capsule to tear, the head of the phalanx can buttonhole thru the defect and the lateral bands of the extensor tendons fall laterally & contract
• The lateral bands then function as PIP flexors and not extensors
• DIP hyperextension due to excessive pull of the displaced lateral bands
• As a result, the pateint WILL be able to flex the DIP joint, but WILL NOT be able to extend   the PIP joint                                                                    
• OCCURS 1 - 3 weeks post injury
• May not present with classic textbook deformity
• The Elson test is the best way to detect the injury pattern before the deformity is evident
• https://www.youtube.com/watch?v=G9HY0qXWUvE

Recently, an ex-Russian spy and his daughter were poisoned in Salisbury, England using a Soviet nerve agent called Novichok. He joins a list of defectors and ex-spies who's poisoning have been connected to Russia.

Nerve agents are organophosphate compounds, similar to the commercially available pesticides, but significantly more potent. Nerve agents such as VX take seconds to minutes to irreversibly inhibit acetylcholinesterase by “aging” and result in clinical toxicity. 

Signs and symptoms

• Muscarinic: DUMBELS or SLUDGE and Killer B's
• Nicotinic: muscle weakness & paralysis

Treatment

• Decontamination
• Atropine – 2 mg IV and double the dose every 3 – 5 minutes until clearing of bronchorrhea, bronchospasm and bradycardia
• Pralidoxime – reverses inhibition of acetylcholinesterases that are not aged

Worsening hypoxemia is not uncommon upon initiation of VV ECMO for severe ARDS as tidal volumes drop to double digits  (often <20cc) after transition to “lung rest” ventilator settings. The following are strategies to improve peripheral oxygenation:

1. Increase the blood’s oxygen content

-       Ensure FIO2 of ECMO sweep gas is 1

-       Increase ECMO blood flow

o   Limited by cannula size and configuration – may require placement of additional venous drainage cannula

o   Also limited by greater risk of recirculation and hemolysis

-       Increase blood oxygen-carrying capacity

o   Transfuse PRBCs – some advocate for goal hemoglobin 12-14, though institutional practices vary significantly

2. Minimize recirculation

-       Maximize distance between drainage and return cannulae

3. Reduce oxygen consumption

-       Optimize sedation and neuromuscular blockade. (This is not the appropriate scenario for awake ECMO.)

-       Consider therapeutic hypothermia

4. Decrease cardiac output and intrapulmonary shunt

-       Consider beta blocker (esmolol) infusion

-       Prone positioning (only if staff are experienced with proning on ECMO as this poses significant risk of cannula displacement)

5. Consider switching to hybrid configuration (VVA – continued venous drainage cannula and venous return cannula with addition of arterial return cannula)  

Show References

Peri-Intubation Cardiac Arrest

• Endotracheal intubation is a high-risk procedure, especially in the critically ill patient.
• The incidence of peri-intubation cardiac arrest ranges from 2% to 5%, and is associated with significant increases in morbidity and mortality.
• Authors of a recent retrospective analysis across 64 French ICUs sought to determine risk factors for cardiac arrest during ICU intubation.
• Among 1,847 intubations, the main predictors of cardiac arrest during intubation were:
  • Pre-intubation arterial hypotension (SBP < 90 mm Hg) (OR 3.4)
  • Pre-intubation hypoxemia (OR 3.99)
  • Absence of preoxygenation (OR 3.58)
  • Obesity (OR 2)
  • Age > 75 years of age (OR 2.25)
• Take Home Point
  • Pay close attention to these risk factors and "resuscitate before you intubate".

Show References

Fluid overload (defined in this study as (fluid input-output)/weight)) is associated with longer hospital stays, longer treatment duration and oxygen use.

Bottom line: Treat dehydration appropriately but try not to over resuscitate the asthmatic.  Further studies are needed before definitive recommendations are made.

Show Additional Information

Show References

• A recent systematic review evaluated the diagnostic accuracy of 19 prehospital stroke scales.
• Arm motor strength is the most frequently evaluated item by the scales (15/19), followed by gaze (13/19) and language (13/19).
• Only 4 scales (RACE, LAMS, VAN, sNIHSS-EMS) were performed by paramedics in their original studies.
• The NIHSS, LAMS, and VAN appear to have better results in predicting large vessel occlusion.
• The presence of hemineglect, a sign of cortical involvement, improved the accuracy of the scale.

Show Additional Information

Show References

Pectoralis Major Rupture

Most commonly seen in male weightlifters

Usually occurs as a tendon avulsion

Incidence is increasing

Hx: Sudden, sharp, tearing sensation with pain and weakness with arm movement

PE: Palpable defect and deformity of anterior axillary fold. Bruising and swelling.

               Deformity may not be obvious with arm by side and relaxed

Testing: Weakness with ADDuction and internal rotation

https://lh3.googleusercontent.com/wQcuu_sG76t_DLWocO_c2344IT69g_vWXY0FKtqhR4L37qrrsIuW607LZkVFT8QTLAdaTeU=s170

Treatment:  Operative treatment has better outcomes but depends on patient subgroups

Nonoperative treatment generally indicated for partial ruptures and tears in the body of the pec and muscle tendon junction

               Sling, ice and pain control.

Operative treatment generally for high demand patients (athletes) and bony avulsion injuries

Signs and symptoms of acute cyanide poisoning are not well characterized due to its rare occurrence.  Commonly mentioned characteristics of bitter almond odor and cherry red skin have poor clinical utility.

Recently published review of 65 articles (102 patients) showed that most patients experienced following signs and symptoms:

1. Unresponsive: 78%
2. Respiratory failure: 73%
3. Hypotension: 54%
4. Cardiac arrest: 20%
5. Seizure: 20%
6. Cyanosis: 15%
7. Odor: 15%
8. Cherry red skin: 11%

There is no clear toxidrome for cyanide poisoning.

In a poisoned patient, health care providers should consider cyanide in their differential diagnosis in the presence of severe metabolic and lactic acidosis (lactic acid > 8 in isolated cyanide poisoning or > 10 in smoke/fire victim).

Show References